focus -WSS

focus

author：hotspot 2025-09-30 22:06:30 - browse：1921

Adam's take main illustration — Molly Ferguson/STAT

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

Do you have a biotech-related question you want me to answer in the newsletter? Send me an email at [email protected].

This week: A preview of Intra-Cellular Therapies’ Phase 3 study in major depressive disorder, and a couple of liver-disease physician perspectives on Rezdiffra, the newly approved treatment for MASH from Madrigal Pharmaceuticals.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Medicare drug price negotiation continues, as pharma counteroffers

focus

WSS

Stem cell biologist probes earliest stages of human development

After gene therapy, two congenitally deaf children hear for the first time

Bird flu outbreak in cows is latest avian flu curveball

Pregnant women don't need prenatal multivitamins, study concludes

Florida health officials providing scant details on measles cases

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

focus

focus

explore

Medicare details structure of new drug price negotiation program

Sanofi strikes deal with Novavax, boosting the vaccine maker

Trump demands the U.S. pay no more for drugs than other countries … again

Microsoft's Peter Lee: Generative AI could help doctors be more human

Hollywood unions extend contract negotiations for actors

Stem cell biologist probes earliest stages of human development

Supreme Court strikes down use of affirmative action

State of the Union pitch: Bigger Medicare drug price negotiations

Duchenne breakthrough therapy leaves behind pioneering families

Medicare drug price negotiation hearing pits pharma v Biden admin

hotspot

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Lack of health data on LGBTQ+ people has serious consequences

Families look for replacement for GSK asthma drug Flovent

Stem cell biologist probes earliest stages of human development

Change Healthcare: What is it, why does its cyberattack matter?

Brain worms: The science behind RFK Jr.'s parasitic infection

Wikipedia

knowledge

focus

knowledge